Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders
- PMID: 38474324
- PMCID: PMC10931734
- DOI: 10.3390/ijms25053079
Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders
Abstract
Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...].
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
The Current State of Advanced Therapy Medicinal Products in the Czech Republic.Hum Gene Ther Clin Dev. 2018 Sep;29(3):132-147. doi: 10.1089/humc.2018.035. Epub 2018 Jul 13. Hum Gene Ther Clin Dev. 2018. PMID: 29869533
-
19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products).Expert Opin Drug Saf. 2020 May;19(5):553-558. doi: 10.1080/14740338.2020.1741546. Epub 2020 Mar 20. Expert Opin Drug Saf. 2020. PMID: 32163309
-
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.Adv Exp Med Biol. 2015;871:103-30. doi: 10.1007/978-3-319-18618-4_6. Adv Exp Med Biol. 2015. PMID: 26374215 Review.
-
Regulatory Frameworks for Advanced Therapy Medicinal Products in Thailand.Adv Exp Med Biol. 2023;1430:221-233. doi: 10.1007/978-3-031-34567-8_13. Adv Exp Med Biol. 2023. PMID: 37526851 Review.
-
The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time.Transpl Int. 2023 Sep 27;36:11633. doi: 10.3389/ti.2023.11633. eCollection 2023. Transpl Int. 2023. PMID: 37822447 Free PMC article.
References
-
- Jönsson B., Grace H., Michaels J., Towse A., Graf Von Der Schulenburg J.-M., Olivier W. Advanced Therapy Medicinal Products and Health Technology Assessment Principles and Practices for Value-Based and Sustainable Healthcare. Eur. J. Health Econ. 2019;20:427–438. doi: 10.1007/s10198-018-1007-x. - DOI - PMC - PubMed
-
- FDA. CBER . Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and Food and Drug Administration Staff Contains Nonbinding Recommendations Draft-Not for Implementation. Center for Biologics Evaluation and Research; Silver Spring, MD, USA: 2014.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical